The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Layla 1. I understand where you’re coming from, but an appropriate value is expected to be added to a company when favorable. We have decreased risk and also added to reserves. Can you imagine if no value was credited to all companies in
the FTSE or AIM the stock market would cease to exist.
Range binding and manipulating a share only serves to dampen the spirit of investing. MMs are giving nothing here. 2.7b shares in circulation the huge majority of which are held by LTHs and benefits are only granted to traders and a few rinse and repeat sellers. I firmly believe that MMS do have an inclination as to what value a share may be worth. If this sells for something like what is being suggested. There’s going to be a huge disparity and they should be accountable for their standards.
MMS and traders playing this, they seem to have the advantage even when good news is released. LTHs who hold the huge majority of the shares expect a rise when news of this caliber is released. So corrupt! FCA really need to get their act together and investigate.
Interesting Lamstree, what’s your agenda? Is it to save us all from loosing money by selling up, whilst you benefit by buying cheaper.
Do you really think you can sway investors by some of the rubbish you post and that they are so naive.